Response to: risk of lung disease with the Pi*SS genotype of alpha-1 antitrypsin: the evidence in context.
作者信息
Martín Teresa, Miravitlles Marc
机构信息
Pneumology Department, Hospital Beatriz Ângelo, Av. Carlos Teixeira 3, Loures, 2674-514, Portugal.
Pneumology Department, Hospital Universitari Vall d'Hebron/Vall d'Hebron Research Institute (VHIR), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
出版信息
Respir Res. 2025 Jan 24;26(1):36. doi: 10.1186/s12931-024-03065-w.
Abstract
摘要
相似文献
1
Response to: risk of lung disease with the Pi*SS genotype of alpha-1 antitrypsin: the evidence in context.回应：α-1抗胰蛋白酶Pi*SS基因型与肺部疾病风险：相关证据
Respir Res. 2025 Jan 24;26(1):36. doi: 10.1186/s12931-024-03065-w.
2
Risk of lung disease in the PI*SS genotype of alpha-1 antitrypsin: an EARCO research project.PI*SS 基因型的α-1 抗胰蛋白酶缺乏症与肺部疾病风险：EARCO 研究项目。
Respir Res. 2024 Jun 26;25(1):260. doi: 10.1186/s12931-024-02879-y.
3
Risk of lung disease with the Pi*SS genotype of alpha-1 antitrypsin: the evidence in context.α-1抗胰蛋白酶Pi*SS基因型与肺部疾病的风险：相关证据概述
Respir Res. 2025 Jan 24;26(1):37. doi: 10.1186/s12931-024-03066-9.
4
Pulmonary Function and Respiratory Diseases in Different Genotypes of Alpha-1 Antitrypsin Deficiency.α-1抗胰蛋白酶缺乏症不同基因型中的肺功能与呼吸系统疾病
Turk Thorac J. 2022 Nov;23(6):376-382. doi: 10.5152/TurkThoracJ.2022.22001.
5
Alpha-1 antitrypsin (AAT) augmentation therapy in individuals with the PI*MZ genotype: a pro/con debate on a working hypothesis.针对 PI*MZ 基因型个体的α-1 抗胰蛋白酶（AAT）增强疗法：针对一个工作假设的赞成/反对辩论。
BMC Pulm Med. 2021 Mar 23;21(1):99. doi: 10.1186/s12890-021-01466-x.
6
Association between circulating alpha-1 antitrypsin polymers and lung and liver disease.循环α-1 抗胰蛋白酶聚合物与肺和肝疾病的关系。
Respir Res. 2021 Sep 15;22(1):244. doi: 10.1186/s12931-021-01842-5.
7
Clinical considerations in individuals with α-antitrypsin PI*SZ genotype.具有 α-抗胰蛋白酶 PI*SZ 基因型个体的临床注意事项。
Eur Respir J. 2020 Jun 18;55(6). doi: 10.1183/13993003.02410-2019. Print 2020 Jun.
8
Frequency of alleles and genotypes associated with alpha-1 antitrypsin deficiency in clinical and general populations: Revelations about underdiagnosis.与α-1 抗胰蛋白酶缺乏症相关的等位基因和基因型在临床和一般人群中的频率：关于漏诊的启示。
Pulmonology. 2023 May-Jun;29(3):214-220. doi: 10.1016/j.pulmoe.2022.01.017. Epub 2022 Mar 26.
9
Alpha-1 Antitrypsin Augmentation and the Liver Phenotype of Adults With Alpha-1 Antitrypsin Deficiency (Genotype Pi∗ZZ).α-1 抗胰蛋白酶增强治疗与 α-1 抗胰蛋白酶缺乏症成人的肝脏表型（基因型 Pi∗ZZ）
Clin Gastroenterol Hepatol. 2024 Feb;22(2):283-294.e5. doi: 10.1016/j.cgh.2023.08.038. Epub 2023 Sep 15.
10
Family study of alpha 1-antitrypsin deficiency: effects of cigarette smoking, measured genotype, and their interaction on pulmonary function and biochemical traits.α1-抗胰蛋白酶缺乏症的家系研究：吸烟、测量基因型及其相互作用对肺功能和生化特征的影响。
Genet Epidemiol. 1992;9(5):317-31. doi: 10.1002/gepi.1370090504.
本文引用的文献
1
Personalised indication of augmentation therapy for emphysema associated with severe alpha-1 antitrypsin deficiency: a case series.与严重α-1 抗胰蛋白酶缺乏症相关的肺气肿的增强治疗的个体化指征：病例系列。
Ther Adv Respir Dis. 2024 Jan-Dec;18:17534666241271917. doi: 10.1177/17534666241271917.
2
Risk of lung disease in the PI*SS genotype of alpha-1 antitrypsin: an EARCO research project.PI*SS 基因型的α-1 抗胰蛋白酶缺乏症与肺部疾病风险：EARCO 研究项目。
Respir Res. 2024 Jun 26;25(1):260. doi: 10.1186/s12931-024-02879-y.
3
Nine controversial questions about augmentation therapy for alpha-1 antitrypsin deficiency: a viewpoint.九个关于α-1 抗胰蛋白酶缺乏症增强治疗的有争议问题：观点。
Eur Respir Rev. 2023 Dec 6;32(170). doi: 10.1183/16000617.0170-2023. Print 2023 Dec 31.
4
Augmentation Therapy for Severe Alpha-1 Antitrypsin Deficiency Improves Survival and Is Decoupled from Spirometric Decline-A Multinational Registry Analysis.严重α-1 抗胰蛋白酶缺乏症的增强治疗可改善生存，与肺功能下降脱钩——一项多国登记分析。
Am J Respir Crit Care Med. 2023 Nov 1;208(9):964-974. doi: 10.1164/rccm.202305-0863OC.
5
Serum levels and genotype distribution of α1-antitrypsin in the general population.α1-抗胰蛋白酶在普通人群中的血清水平和基因型分布。
Thorax. 2012 Aug;67(8):669-74. doi: 10.1136/thoraxjnl-2011-201321. Epub 2012 Mar 16.
Zotero 插件